Related Experiment Video
Updated: Aug 30, 2026
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography
Hisataka Kobayashi1, Satomi Kawamoto, Peter L Choyke
1Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1374, USA. Kobayash@mail.nih.gov
Abstract:
Few methods are currently available to visualize the entire lymphatic system. A method known as micro-magnetic resonance lymphangiography (MRL), which employs a dendrimer-based MRI contrast agent (PAMAM-G8) and a clinical-grade 1.5T MRI instrument, was recently developed for use in mice. In the present study, three dendrimer-based MRI contrast agents (PAMAM-G8, DAB-G5, and PAMAM-G4) with different pharmacokinetic characteristics were compared to determine the best reagent to visualize the lymphatic system under physiological or pathological conditions. In addition, two established MRI contrast agents (Gadomer-17 and Gd-[DTPA]-dimeglumine (Magnevist)) were used as control agents. In experiments with mice, most of the deep lymphatic system was visualized by micro-MRL with all agents except Gd-[DTPA]-dimeglumine. PAMAM-G8 was best for visualizing lymphatic vessels, whereas DAB-G5 was better for visualizing lymph nodes. PAMAM-G4 was intermediate in character between PAMAM-G8 and DAB-G5, except in exhibiting a low background signal (especially in the liver). The lymphatic system was not clearly visualized with Gd-[DTPA]-dimeglumine; however, the lymph nodes were visualized with Gadomer-17, although not as well as with dendrimer-based agents. In conclusion, DAB-G5 and PAMAM-G4 can be used to identify lymph nodes and lymphatic vessels, respectively. Their rapid excretion makes these compounds potentially attractive for human use.
Insights
New dendrimer-based MRI contrast agents effectively visualize the lymphatic system in mice. PAMAM-G8 excels at imaging lymphatic vessels, while DAB-G5 is superior for lymph node visualization, offering potential for human applications.
Area of Science:
- Biomedical Imaging
- Radiology
- Nanotechnology
Background:
- Visualizing the entire lymphatic system remains challenging due to limited available methods.
- Micro-magnetic resonance lymphangiography (MRL) using dendrimer-based contrast agents (e.g., PAMAM-G8) has shown promise in preclinical mouse models.
- Developing effective contrast agents is crucial for understanding lymphatic system function in both normal and disease states.
Purpose of the Study:
- To compare the efficacy of three dendrimer-based MRI contrast agents (PAMAM-G8, DAB-G5, PAMAM-G4) for visualizing the lymphatic system.
- To evaluate their performance under physiological and pathological conditions in mice.
- To assess their suitability against established MRI contrast agents (Gadomer-17, Magnevist).
Main Methods:
- Micro-magnetic resonance lymphangiography (micro-MRL) was performed on mice.
- Three dendrimer-based MRI contrast agents (PAMAM-G8, DAB-G5, PAMAM-G4) and two control agents (Gadomer-17, Gd-[DTPA]-dimeglumine) were administered.
- The visualization quality of the deep lymphatic system and lymph nodes was assessed for each agent.
Main Results:
- Micro-MRL visualized most of the deep lymphatic system with all agents except Gd-[DTPA]-dimeglumine.
- PAMAM-G8 demonstrated superior visualization of lymphatic vessels.
- DAB-G5 was more effective for lymph node imaging, while PAMAM-G4 showed intermediate results with low background signal.
- Gadomer-17 visualized lymph nodes but less effectively than dendrimer agents; Gd-[DTPA]-dimeglumine provided poor lymphatic system visualization.
Conclusions:
- Dendrimer-based agents DAB-G5 and PAMAM-G4 are effective for identifying lymph nodes and lymphatic vessels, respectively.
- The rapid excretion profiles of these agents suggest potential for future human applications.
- Micro-MRL with optimized dendrimer agents offers a promising approach for lymphatic system imaging.
